Mounjaro and Kidney Stones: What People on Tirzepatide Should Know

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist prescribed once weekly as an injectable medicine. At present, kidney stones are not identified as a commonly reported adverse effect in its prescribing information. However, there are a few indirect connections worth being aware of.

Hydration and Stone Risk

One of the most well-established risk factors for kidney stones is inadequate fluid intake. Because Mounjaro commonly reduces appetite and, for some people, the desire to drink as much as usual, there is a practical consideration: staying consistently hydrated becomes especially important. Many people on GLP-1 or dual GIP/GLP-1 medicines find they need to make a conscious effort to drink enough water each day, as reduced food noise can also reduce the prompt to reach for a glass.

Kidney Function More Broadly

Research into GLP-1 receptor agonists and kidney function is ongoing. Some studies have explored whether GLP-1 pathways may have a protective effect on kidney health over time, though this remains an active area of investigation and does not replace individual clinical assessment. If you have a history of kidney pain or related symptoms, or a pre-existing kidney condition, it is important to discuss this with your prescriber before or during your treatment — your prescriber or doctor is best placed to assess how Mounjaro interacts with your specific history.

Mounjaro and Kidney Disease

People with significant kidney impairment may have different considerations when using tirzepatide. Dose decisions and suitability for people with kidney disease are always a matter for a prescriber, and this page does not offer guidance on whether or how to adjust treatment. For further detail on this topic, you may find it helpful to read more about kidney stones and tirzepatide in the context of your own medical history, always guided by your healthcare professional.

If you experience symptoms such as severe flank or back pain, pain when passing urine, blood in your urine, or nausea that feels different or more intense than your usual GLP-1-related side effects, contact your healthcare professional promptly — do not attempt to self-diagnose or manage these symptoms without clinical input.

When it comes to kidney health, two of the most practical things you can do while on Mounjaro are track your daily water intake and log any new or unusual symptoms so you can report them accurately to your prescriber.

GLP Trackr's daily check-in and targets feature lets you set a personal water goal and log your intake every day — a simple but effective way to make sure reduced appetite is not quietly affecting how much you drink. If you find your fluid intake dropping, you will have the data to notice the pattern and act on it.

The app's side-effect tracker lets you log and date any physical symptoms — including pain, discomfort, or anything that feels unusual — and view them over time. That kind of structured record is genuinely useful to bring to a prescriber appointment, far more so than trying to recall symptoms from memory weeks later. You can also use the doctor report feature to put together a clear summary of your journey ahead of any clinical review.

GLP Trackr is a tracking and journaling tool — it is not a substitute for your prescriber's advice. Always follow the guidance of your doctor or prescriber, and if symptoms are severe, persistent, or worrying, seek medical attention promptly. Any concerns about your kidney health or how Mounjaro may affect it should be discussed directly with your healthcare professional.

You can also explore more about Mounjaro and other health conditions being discussed in the GLP-1 community, or read the broader Mounjaro information hub for a fuller picture of what to expect on tirzepatide.

Log your symptoms, hit your water targets, and keep your prescriber informed — GLP Trackr is free to try for a full week on the App Store and Google Play. Download it and start your 7-day trial today.